- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05753982
Infuence of Kinesiotaping on Pulmonary Function Improvement in Multiple Rib Fracture
Study Overview
Detailed Description
Chest wall injury changes the function of chest wall muscles and other structures, which in turn influences respiratory function and cause significant pain.
Elastic tapes, named "kinesiotapes" have a limited, but proven influence on pain reduction, improvement in muscular strength and joint function. It can be hypothetised that by using kinesiotape techniques on damaged chest wall (due to mostly rib fracture) we can improve not only analgesia, but also improve lung function tests and speed recovery.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- University Medical Centre Ljubljana
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Unilateral chest wall injury with multiple rib fracture (< 5 ribs)
- Signed informed consent
Exclusion Criteria:
- Minors
- Pregnant women
- Contraindications of using kinesiotapes
- Contraindications to perform spirometry (lung function tests)
- Inability to cooperate
- Chest drains
- Pneumothorax
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: kinesiotape
Placement of kinesiotapes, using ligament techniques on the injured side of chest, focusing on the point of maximal pain.
|
Placement of kinesiotapes, using ligament techniques on the injured side of chest, focusing on the point of maximal pain.
|
|
Placebo Comparator: control
No kinesiotape, standard of care
|
Placement of kinesiotapes, using ligament techniques on the injured side of chest, focusing on the point of maximal pain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improved spirometry tests
Time Frame: 2 days
|
Improvement in lung function using spirometry
|
2 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in opioid consumption
Time Frame: 2 days
|
Reduction in consumtion of opioid analgetic drugs
|
2 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kinesiotape_RT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.